Capstone Wealth Management Group (Pennsylvania)’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $244K | Sell |
1,317
-938
| -42% | -$174K | 0.23% | 48 |
|
|
2025
Q1 | $473K | Sell |
2,255
-820
| -27% | -$172K | 0.27% | 50 |
|
|
2024
Q4 | $546K | Sell |
3,075
-441
| -13% | -$78.4K | 0.29% | 57 |
|
|
2024
Q3 | $694K | Buy |
3,516
+26
| +0.7% | +$5.14K | 0.41% | 47 |
|
|
2024
Q2 | $599K | Buy |
3,490
+10
| +0.3% | +$1.72K | 0.39% | 51 |
|
|
2024
Q1 | $634K | Buy |
3,480
+39
| +1% | +$7.1K | 0.45% | 47 |
|
|
2023
Q4 | $533K | Buy |
3,441
+217
| +7% | +$33.6K | 0.5% | 38 |
|
|
2023
Q3 | $481K | Buy |
3,224
+471
| +17% | +$70.2K | 0.5% | 38 |
|
|
2023
Q2 | $371K | Buy |
2,753
+26
| +1% | +$3.5K | 0.38% | 45 |
|
|
2023
Q1 | $435K | Buy |
2,727
+54
| +2% | +$8.61K | 0.48% | 35 |
|
|
2022
Q4 | $432K | Buy |
2,673
+24
| +0.9% | +$3.88K | 0.46% | 40 |
|
|
2022
Q3 | $356K | Buy |
2,649
+347
| +15% | +$46.6K | 0.46% | 42 |
|
|
2022
Q2 | $353K | Buy |
2,302
+69
| +3% | +$10.6K | 0.43% | 46 |
|
|
2022
Q1 | $362K | Buy |
2,233
+21
| +0.9% | +$3.4K | 0.36% | 47 |
|
|
2021
Q4 | $299K | Buy |
+2,212
| New | +$299K | 0.24% | 65 |
|